isoxazoles has been researched along with Hypertrophy, Left Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frangogiannis, NG; Fujikura, K; Garcia, MJ; Palanski, BA; Shinde, AV; Su, Y | 1 |
Combe, B; Cristol, JP; Daïen, CI; Daïen, V; du Cailar, G; Dupuy, AM; Fesler, P; Morel, J; Mura, T; Ribstein, J | 1 |
1 trial(s) available for isoxazoles and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Echocardiography; Etanercept; Female; Humans; Hypertrophy, Left Ventricular; Immunoglobulin G; Isoxazoles; Leflunomide; Methotrexate; Middle Aged; Pulse Wave Analysis; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Stiffness | 2013 |
1 other study(ies) available for isoxazoles and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
Topics: Animals; Cardiomegaly; Collagen; Diastole; Extracellular Matrix; Female; Fibroblasts; Fibrosis; GTP-Binding Proteins; Hypertrophy, Left Ventricular; Isoxazoles; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Pressure; Protein Glutamine gamma Glutamyltransferase 2; Pyrrolidines; Quinolines; Recombinant Proteins; Stroke Volume; Tissue Inhibitor of Metalloproteinases; Transcription, Genetic; Transglutaminases; Up-Regulation; Ventricular Remodeling | 2018 |